Frequency of Thalassemia in Iran and Khorasan Razavi

International Journal of Pediatrics

Volumn 1, Issue 1, 2013, Pages 45-50

  Khodaei, Gholam Hasan ^a   Farbod, Nasrin ^a   Saeidi, Masumeh ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Belt Thalassemia; Iran; Khorasan Razavi; Prevalence; Thalassemia

Indexed keywords

EID: 85006856388     PISSN: None     EISSN: 23455055     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Najmabadi H, Pourfathollah AA, Neishabury M, Sahebjam F, Krugluger W, Oberkanins C. Rare and unexpected mutations among Iranian β-Thalassemia patients and prenatal samples discovered by reverse-hybridization and DNA sequencing. Haematologica. 2002; 87(10): 1113-14.
2. Garshasbi M, Oberkanins C, Law HY, Neishabury M, Kariminejad R, Najmabadi H. a-globin gene deletion and point mutation analysis among Iranian patients with microcytic hypochromic anemia. Haematologica. 2003;88 (10):1196-1197.
3. Ryan K, Bain BJ, Worthington D, James J, Plews D, Mason A, Roper D, Rees DC, de la Salle B, Streetly A; British Committee for Standards in Haematology. Significant haemoglobinopathies: guidelines for screening and diagnosis. Br J Haematol. 2010 Apr;149(1): 35-49.
4. Weatherall DJ, Clegg JB. Inherited haemoglobin disorders: an increasing global health problem. Bull World Health Organ. 2001; 79(8):704-12. Epub 2001 Oct 24.
5. Fucharoen S, Winichagoon P. Prevention and control of thalassemia in Asia. Asian Biomed J. 2007; 1:1.
6. Alhamdan NA, Almazrou YY, Alswaidi FM, Choudhry AJ. Premarital screening for thalassemia and sickle cell disease in Saudi Arabia. Genet Med. 2007 Jun; 9(6):372-7.
7. Sarper N, Senkal V, Guray F, Sahin O, Bayram J. Premarital hemoglobinopathy screening in Kocaeli, Turkey: a crowded industrial center on the north coast of Marmara Sea. Turk J Hematol. 2009; 26:62-66.
8. Haddow JE. Couple screening to avoid thalassemia: successful in Iran and instructive for us. J Med Screen. 2005;12(2):55-6.
9. Samavat A, Modell B. Iranian national thalassaemia screening programme. BMJ. 2004 Nov 13; 329(7475):1134-7.
10. Moafi A, Valian S, Nikyar Z, Zeinalian M, Momenzadeh M, Rahgozar S (2010) Prevalence of minor β-thalassemia based on RBC indices. Int J Hematol Onchol Stem Cell Res 2010:23-7.
11. Verma IC, Saxena R, Kohli S. Past, present & future scenario of thalassaemic care & control in India. Indian J Med Res. 2011 Oct;134:507-21.
12. Langlois S, Ford J, Chitayat D. Carrier screening for thalassemia and hemoglo-binopathies in Canada. J Obstet Gynaecol Can. 2008 Oct; 30(10):950-71.
13. Iranian Health Ministry.Comprehensive Guideline for National Prevention and Control Programme for beta-thalassaemia. Health Deputy, Genetics Office (2004).
14. Haghshenas M, Zamani J. Thalassemia. 1. Shiraz: Shiraz University of Medical Sciences Publishing Center; 1997.
15. Iranian Health Ministry Management feature of major beta-thalassaemia incidence in Iran. Health Deputy, Genetics Office (2008).
16. Weatherall DJ. Thalassemia as a global health problem: recent progress toward its control in the developing countries. Ann N Y Acad Sci. 2010 Aug; 1202: 17-23.
17. Harteveld CL, Higgs DR. Alpha-thalassaemia. Orphanet J Rare Dis. 2010 May 28; 5:13.
18. Galanello R, Origa R. Beta-thalassemia. Orphanet J Rare Dis. 2010 May 21; 5: 11.